Additional file 4 of EPHA7 mutation as a predictive biomarker for immune checkpoint inhibitors in multiple cancers

Additional file 4: Figure S2. Truncating vs non-truncating EPHA7 mutation analysis in both discovery and validation cohort. Figure S2 A-D: discovery cohort. Figure S2 E: validation cohort.